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ABSTRACT
This report describes the second case of a superior
mesenteric and portal vein thrombosis following an
uneventful laparoscopic Nissen fundoplication. The
patient presented on postoperative day 10 with acute
onset of abdominal pain and inability to tolerate oral
food. A computed tomography (CT) scan revealed supe-
rior mesenteric and portal venous thrombosis with ques-
tionable viability of the proximal small bowel. He was
heparinized and taken for emergent exploratory laparo-
tomy. At surgery and at a planned re-exploration the fol-
lowing day, the bowel was viable and no resection was
needed. Despite continuation on anticoagulation thera-
py, he developed a pulmonary embolism. A hypercoag-
ulable workup was normal. After continued anticoagula-
tion therapy and supportive care, a duplex ultrasound 2
months after the event showed normal flow in both the
superior mesenteric and portal veins. Possible mecha-
nisms are discussed along with a review of the pertinent
literature.
Key Words: Fundoplication, Laparoscopy, Mesenteric
vein thrombosis.
INTRODUCTION
Laparoscopic Nissen fundoplication is a common proce-
dure performed in many patients experiencing sympto-
matic gastric esophageal reflux. Common complications
associated with the procedure include pain, bleeding,
infection, failure of the procedure, and gas-bloat syn-
drome. As part of the technique, carbon dioxide is used
to create a pneumoperitoneum. This has been described
to cause reduction in portal venous flow. In addition, this
has been associated with superior mesenteric and portal
vein thrombosis in certain laparoscopic-assisted surger-
ies. To our knowledge, this is the second case of a supe-
rior mesenteric and portal vein thrombosis following
laparoscopic Nissen fundoplication.
CASE REPORT
A 36-year-old otherwise healthy male presented with 2
years of symptomatic reflux disease, nonresponsive to
proton pump inhibitors. A preoperative esophagogastro-
duodenoscopy showed mild esophageal reflux, manom-
etry was normal, and 24-hour pH study demonstrated a
DeMeester score of 83 (normal less than 14.72). His past
medical history was unremarkable. The patient had no
family or personal history of stroke, deep venous throm-
bosis, or bleeding disorders. He did smoke approxi-
mately 1/2 to 1 pack of cigarettes per day. He was admit-
ted to the hospital and underwent an uncomplicated
elective laparoscopic Nissen fundoplication. Perioper-
atively, he was not given subcutaneous heparin or low-
molecular weight heparin. He did have sequential com-
pression devices on during surgery. The total operative
time was 92 minutes with peak intraabdominal pneu-
moperitoneum pressures at 15 mm Hg. He was dis-
charged home on postoperative day 2 after an uncom-
plicated hospital stay.
He presented to an outside clinic on postoperative day
10 with complaints of diarrhea and some nausea. He was
afebrile with a normal white blood cell count and liver
function tests. An acute abdominal test series was unre-
markable. He was rehydrated with 2 liters of normal
saline, and after feeling better, discharged home. He re-
presented the following morning to our hospital emer-
gency department with diffuse abdominal pain and loose
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stools. Vital signs and laboratory examinations were nor-
mal. Abdominal films showed a dilated colon with
colonic air-fluid levels. He was observed overnight and
started empirically on flagyl for presumed C. dificile coli-
tis. The following morning, he remained in considerable
pain, but with normal vital signs and laboratory evalua-
tion. An abdominal computed tomography (CT) scan
demonstrated superior mesenteric and portal venous
thrombosis with questionable viability of the proximal
small bowel (Figures 1 and 2). He was started on
heparin and taken for emergent exploratory celiotomy.
The small bowel was thickened, but viable, and an
appendectomy with manual decompression of the bowel
was performed. The patient was continued on heparin
overnight, and the scheduled re-exploration laparotomy
the following morning again demonstrated viable bowel.
He was continued on heparin, and extubated on postop-
erative day 3. He did well until the morning of postoper-
ative day 5 when he was noted to be acutely tachypneic
with oxygen desaturation and tachycardic. A duplex
ultrasound of the bilateral upper extremity and lower
extremity showed only a clot surrounding his left internal
jugular line. He was intubated and a chest CT scan
demonstrated bilateral lower lobe infiltrates. A pulmonary
angiogram demonstrated a right lower lobe pulmonary
emboli extending into the medial basal branch of the
right pulmonary artery. Over the next week, he was
resuscitated, heparinized, and treated for concomitant
pneumonia and pancreatitis. He eventually did well and
was discharged 1 week later on oral anticoagulation. The
follow-up extremity duplex at 1 month showed no upper
extremity or lower extremity venous thrombosis, as well
as a re-canalized left internal jugular vein with a small
amount of residual thrombosis.
The patient had no other risk factors for hypercoagula-
bilty except for his recent laparoscopic surgery and
history of tobacco use. Hematological studies that includ-
ed antiphospholipid antibody, lupus anticoagulant,
antithrombin III, protein C, protein S, anticardiolipin anti-
body, homocysteine, APC-Resistant factor V, PT 20210,
and factor V Leyden were all normal.
The patient was continued on oral anticoagulation as an
outpatient, and a follow-up duplex ultrasound at 2
months demonstrated normal flow in the superior mesen-
teric and portal vein with no sign of thrombus. The
patient remained clinically asymptomatic.
DISCUSSION
Gastroesophageal reflux disease (GERD) has gone from
a little known disorder in the 1930s to one of the most
common presenting complaints today to both primary
care physicians and surgeons.1,2 Similarly, antireflux sur-
gery has seen an exponential rise over the past few
decades. Laparoscopic Nissen fundoplication is one of
the mainstays for treatment of this disease, used in
approximately 75% to 80% of most laparoscopic antire-
flux surgery. In comparison with medical therapy, it has
been shown to be both cost-effective, as well as achiev-
ing symptomatic control in over 90% of patients.3,4 It has
the additional benefit of allowing patients the ability to
avoid or reduce daily medications.
Figure 1. CT of the abdomen demonstrating superior mesenteric
vein thrombosis.This surgery has a low morbidity rate of 4% to15%.5
There is a 0.5% rate of early re-operation, and persistent
postoperative dysphagia of 3% to 5%.6 Less commonly
occurring complications associated with the surgery
include gas bloat syndrome, “ slipping”  of the wrap, and
esophageal or stomach perforation, or both of these.7
The Nissen fundoplication is almost always completed as
a laparoscopic operation, with a conversion rate of 3% to
5.2%.2 Laparoscopy presents additional potential compli-
cations, such as trocar injury, pneumothorax (1%), and
pneumomediastinum.8 The effects of the carbon dioxide-
induced pneumoperitoneum have also been shown to
decrease the rate of splanchnic blood flow.9,10
Insufflation pressures of as little as 14 mm Hg have been
shown to reduce portal venous flow by 53%.11 Possible
mechanisms of this include mechanical compression of
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the mesenteric vessels, carbon dioxide-induced
vasospasm, and systemic hypercapnia leading to the
decrease in portal flow.10 Thrombosis in the portal and
superior mesenteric vein due to this reduction in flow
have been described in other laparoscopic cases, such as
laparoscopic right hemicolectomy.12
In only one other case have the effects of pneumoperi-
toneum associated with laparoscopic Nissen fundoplica-
tion been associated with a superior mesenteric and por-
tal venous thrombosis.13 In that case, however, the
patient had had a deep venous thrombosis 13 years prior
to the operation, and a subsequent normal hypercoagu-
lable workup. He also presented with insidious onset of
abdominal pain 2 months after the procedure. A CT scan
demonstrated the thrombus in the superior mesenteric
and portal veins. That patient was treated with coumadin
for 3 months. A follow-up duplex showed normal flow
and he remained asymptomatic. Our patient presented
with acute onset of abdominal pain and a thrombosis
with diffuse vascular engorgement with dilated loops of
thickened small bowel and fat stranding. Heparinization
was immediately started, and he was taken for laparoto-
my due to the question of bowel viability with scheduled
re-exploration in 24 hours.
Mesenteric venous thrombosis is a relatively uncommon
clinical entity, encompassing 5% to 15% of mesenteric
vascular occlusions.14 First described by Elliott15 in 1895,
symptoms can range from an insidious onset of low
grade abdominal pain to acute onset of pain, bowel
ischemia, infarction or perforation requiring urgent
exploratory surgery. Classically, mesenteric venous
thrombosis remains a diagnostic dilemma. History and
physical examination are often unremarkable, making
the clinical diagnosis difficult. Additionally, this happens
in young patients with no predisposing risk factors. The
most common presenting complaint is acute onset of
abdominal pain with progressive signs of bowel
ischemia. Other patients present with a more indolent
pain occurring over the course of weeks to months.16
Pain is characteristically out of proportion to the findings
of the physical examination. Other presenting complaints
include anorexia, diarrhea, nausea and emesis, constipa-
tion, and GI bleeding.17 CT scan and other radiological
imaging, such as ultrasound or angiography, are impor-
tant in helping make this diagnosis. The CT scan remains
the optimal examination, and reveals the thrombus, col-
lateral circulation (when onset is subacute), as well as
any bowel wall changes.17,18
Figure 2. CT of the abdomen demonstrating thickened duode-
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Patients often have a history of an abdominal inflamma-
tory process, or a subsequent hypercoagulable workup is
positive. Protein S deficiency,14 Protein C deficiency,19
primary antiphospholipid antibody,20 factor VII abnor-
malities,21 anticardiolipin antibody,22 myeloproliferative
disease,23 factor IX deficiency,24 and antithrombin III defi-
ciency25 have all been documented in association with
the development of superior mesenteric and portal vein
thrombosis. Some other risk factors associated with the
development of superior mesenteric or portal vein throm-
bosis include cirrhosis and abdominal inflammatory states
like pancreatitis,26 appendicitis, or peritonitis,18 a
delayed diagnosis of malrotation,27 infections with
Yersinia,28 and even young women taking oral contra-
ceptives.29 In most patients, a delay in diagnosis can
range from weeks to years.
Treatment of mesenteric thrombosis depends on the
patient’s clinical state. Treatment can range from antico-
agulation therapy to exploratory laparotomy should signs
of intestinal infarction be present. Surgical thrombecto-
my,30 percutaneous transhepatic thrombectomy,31 and
thrombolytics (urokinase and streptokinase)12,32 have also
been used successfully. As in this case, patients who
present with signs consistent with intestinal infarction
should have a laparotomy with resection as necessary,
followed by planned re-exploration 24 hours later and
anticoagulation.17
Possible causes of superior mesenteric vein thrombosis in
our patient include surgery and effects of the pneu-
moperitoneum. Additionally, he did have a smoking his-
tory, which is known to predispose one to vascular
thrombosis.29 He had no other predisposing conditions.
Although an unknown hypercoaguable disorder may be
present, his initial hematological workup was normal.
Additional screening in the future may be warranted. No
trauma occurred during surgery or kinking of vessels that
have been described in other cases as possible causes.12
Finally, no indications were present of an inflammatory
process, such as pancreatitis, as the inciting event. It is
important to keep in mind that although older studies33
showed no predisposing factors in 55% of patients, more
recent analyses have shown over 80% of patients have
contributing events.34
CONCLUSION
Although this case marks only the second documented
instance of superior mesenteric and portal vein thrombo-
sis following a laparoscopic Nissen fundoplication, as
long-term data begin to grow, the incidence of this
potential complication may increase. Patients who pres-
ent postoperatively with unusual abdominal pain and
otherwise normal vital signs and laboratory examinations
should be evaluated with this potential complication in
mind. In addition, in all cases involving a pneumoperi-
toneum, insufflation pressures should be kept at the low-
est level while still providing optimal visualization.
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